{"name":"Gylden Pharma Ltd","slug":"gylden-pharma-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"PepGNP-ChikV","genericName":"PepGNP-ChikV","slug":"pepgnp-chikv","indication":"Other","status":"phase_1"},{"name":"HD PepGNP-Dengue","genericName":"HD PepGNP-Dengue","slug":"hd-pepgnp-dengue","indication":"Other","status":"phase_1"},{"name":"LD PepGNP-Covid19","genericName":"LD PepGNP-Covid19","slug":"ld-pepgnp-covid19","indication":"Other","status":"phase_1"},{"name":"LD PepGNP-Dengue","genericName":"LD PepGNP-Dengue","slug":"ld-pepgnp-dengue","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"PepGNP-ChikV","genericName":"PepGNP-ChikV","slug":"pepgnp-chikv","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"HD PepGNP-Dengue","genericName":"HD PepGNP-Dengue","slug":"hd-pepgnp-dengue","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"LD PepGNP-Covid19","genericName":"LD PepGNP-Covid19","slug":"ld-pepgnp-covid19","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"LD PepGNP-Dengue","genericName":"LD PepGNP-Dengue","slug":"ld-pepgnp-dengue","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNekMwX3E3TFBwOWM3UmtodFhsTndINzF4X0FEeko3N1ZsUWRZdXlyRXVWTzUxSlFDT1FtOVBMeUF2ek9YUzRLTk9PSU9Ra2tVaWo0VFBkaFp0N2JqOXFKOGxudGVBUWFLOXE2dUhMYl9jSXZoYzRZS2tBSXRGdFcyZ2pyTWR4TWdoSjBIWkF1dXEwdUR0?oc=5","date":"2026-04-02","type":"pipeline","source":"openPR.com","summary":"Market Segmentation, Dynamics, and Competitive Landscape in the Microneedle Flu Vaccine Market - openPR.com","headline":"Market Segmentation, Dynamics, and Competitive Landscape in the Microneedle Flu Vaccine Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxOWmRWTmhJTkZoT0dPNGxzLXYyakQ1NEFVNVdkNDZPdnJ3ZDdVMDNRT2xaLWN1dGVJaHllQlRLNHFtdzhsZlVQOXIxeWFJbGZsQ1lyWl9jWU83YXU1aWc5NWgwbVRZWVYtR0ZoN2pmZDFoUlI5Q2thYXNzLUZUUGR2VzE5VGlTWHB6bEdOelI4MUtSazY0THNKRVFxVjhiR3RQTmI0?oc=5","date":"2025-04-09","type":"pipeline","source":"Drug Target Review","summary":"Gylden’s gold platform trains T cells to kill viruses - Drug Target Review","headline":"Gylden’s gold platform trains T cells to kill viruses","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxNaXM4NDF5dUNyMEtBT2xObXg2bmFqM3A3UVZmRjZCUWZsWVFFVzhkSWNLdGJfaUgxVUVGT2c5aDd4XzMyWmFnOTBTaHlFYmpLcDExLUp2cmszaVFsSEREaGNad19TZFNlZDJuZjRObUZzemFBTmtWTk12ekY1elFtV1hTTUpJempaRjMzcFRzYzE5SmFBRVBxd3R6SjVpdV94TmlqeFExOU5fdWV2WGRLT0NPYUtrd2w3ajdkYVJGRzhidXc2TkVFY0pjSUdWcmZmWmRPVkl5bXdzTXFZaWR1SmV3akJWN1c4Y0prcjBVMkRiWDdYMWNYMUZQLW9uMlJLRlN6MWZnVVI4LUNncUp6UGVJSUZGLUlqS1RveVVQTkFad2ZXOGZMVDVxOWE4emhIalBJSDNoZkg4M0xoMDM4NTFvalY5eHZRcnc?oc=5","date":"2024-10-17","type":"pipeline","source":"GlobeNewswire","summary":"Emergex Announces Company Name Change to “Gylden Pharma - GlobeNewswire","headline":"Emergex Announces Company Name Change to “Gylden Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNWXlxUlRQTjFrVkpYMWR5SEF0WG83OTNQMkJrd0h3VjljeW5JSEdBUFUwa251U3lvSkRuSWJmU0t2UTR3bTMtOUk0TXUzYk5UVWIxSEVOd0ZXTkE2YXlaNVNENGpqSzd6d2EtM3ZNUTlOVm1QS0h5UFRVbTF0VWZNUmEwQUZIV1ozUXRMazZWOEI2OTI3cnlSdnNoeWd0Q084amUwT3RRcUg4MDE5?oc=5","date":"2021-06-01","type":"pipeline","source":"Technology Networks","summary":"Changing Up the Route of Vaccine Administration - Technology Networks","headline":"Changing Up the Route of Vaccine Administration","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_1":4},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}